Page 236 | ASweetLife

Positive Results for Sanofi’s Lyxumia in Treatment of Type 2 Diabetes

Sanofi announced positive results from the Gel Duo 1 study of it's investigational GLP-1 agonist, Lyxumia (lixisenatide) in the treatment of type 2 diabetes patients. The results show that patients with type 2 diabetes uncontrolled on oral anti-diabetics (OADs) – mainly metformin - significantly reduced their HbA1c levels when...

Insulin Therapy Improves Blood Sugar Control in Type 2 Diabetes Patients With Few Hypoglycemic Occurrences

Data from the A1chieve® study, evaluating adverse events and effectiveness of Novo Nordisk insulins (NovoMix 30, Levemir and NovoRapid) in 66,726 people with type 2 diabetes, shows that type 2 diabetes patients can significantly improve their blood glucose control with a low occurrence of low blood sugar (hypoglycemia)...

Fight Diabetes While You Shop

JDRF has partnered with over 700 online stores to raise money for diabetes research. To participate in this fundraiser all you have to do is download the JDRF toolbar, visit the sites of participating merchants, and shop. Every time you make a purchase, JDRF will receive 1%-5% of the price. Not only will the the cost of your purchases not go up, but you'll also be eligible to receive special offers.

My Revel-ations

So, I finally got a new insulin pump, the Minimed Paradigm 523, otherwise known as the Revel. I didn’t want to get it. I’ve been hoping…

Joslin Researchers Help Understand Diabetes in Asian Americans

Researchers at Joslin Diabetes Center have determined key differences between Type 1 and Type 2 diabetes in the Asian American population. This study, published today in PLoS ONE, identified ways to differentiate the types of diabetes, which can be clinically similar in young Asian Americans.

Climbing out of the Wreck

I make one of the world’s worst cheerleaders, but right now I’m shaking some imaginary pompoms (they’re blue, of course) and…

Why Type 2 Diabetes Patients Resist Intensifying Insulin Treatment, Lilly to Conduct Study

Eli Lilly has announced it is conducting the first major international, prospective observational study designed to understand the real-world obstacles (MOSA1c study) that people with type 2 diabetes face which prevent them from reaching their ultimate treatment goals...

FDA Issues Draft Guidance for the Development and Approval of the Artificial Pancreas

The U.S. Food and Drug Administration (FDA) issued draft guidance designed to help investigators and manufacturers as they develop and seek approval for artificial pancreas device systems to treat type 1 diabetes. This step comes after a large campaign led by the Juvenile Diabetes research Foundation ...

Effortless Diabetes Logging: A Review of Glooko

Glooko is a cable that connects iPhones, iPods and iPads to a variety of different glucose meters and automatically downloads blood glucose readings, eliminating the need for you to manually write down records.

A1C and Race Results – Striving for Better

Whenever I run a race, no matter what the distance, I always want to do better than before. I want to set a new personal record. It doesn’t …